SCHEMBL7985609

SCHEMBL7985609

O=c1[nH]c(-c2cccc(O)c2)nc2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.43
MET P08581 1/20 0.43
KMT2A Q03164 1/20 0.42
GSK3B P49841 1/20 0.41
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
RNASEL Q05823 1/20 0.39
ACP1 P24666 2/20 0.39
BRD4 O60885 1/20 0.38
HSD17B13 Q7Z5P4 1/20 0.38
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
EGFR P00533 1/20 0.36
MAPK14 Q16539 1/20 0.36
TYMS P04818 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991634 0.91 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HPGDKMT2AGSK3B
SCHEMBL7988732 0.91 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HPGDMETKMT2A
SCHEMBL7985332 0.91 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HPGDKMT2ARNASEL
SCHEMBL7985561 0.90 HPGD (0.46) ALDH1A1SMN1; SMN2HPGDKMT2ARNASEL
SCHEMBL7988776 0.89 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2HPGDKMT2AIDO1
SCHEMBL7974420 0.89 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDMETKMT2A
SCHEMBL7974275 0.87 HPGD (0.43) ALDH1A1SMN1; SMN2HPGDKMT2ARNASEL
SCHEMBL7986518 0.87 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HPGDMETKMT2A
SCHEMBL7991645 0.87 SMN1; SMN2 (0.47) ALDH1A1SMN1; SMN2HPGDKMT2AACP1
SCHEMBL7984279 0.86 SMN1; SMN2 (0.47) ALDH1A1SMN1; SMN2HPGDMETKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed